Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

TRPV4 Channel Signaling in Macrophages Promotes Gastrointestinal Motility via Direct Effects on Smooth Muscle Cells.

Luo J, Qian A, Oetjen LK, Yu W, Yang P, Feng J, Xie Z, Liu S, Yin S, Dryn D, Cheng J, Riehl TE, Zholos AV, Stenson WF, Kim BS, Hu H.

Immunity. 2018 Jul 17;49(1):107-119.e4. doi: 10.1016/j.immuni.2018.04.021. Epub 2018 Jun 26.

2.

Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells.

Riehl TE, Alvarado D, Ee X, Zuckerman A, Foster L, Kapoor V, Thotala D, Ciorba MA, Stenson WF.

Gut. 2019 Jun;68(6):1003-1013. doi: 10.1136/gutjnl-2018-316226. Epub 2018 Jun 22.

PMID:
29934438
3.

Ibuprofen slows migration and inhibits bowel colonization by enteric nervous system precursors in zebrafish, chick and mouse.

Schill EM, Lake JI, Tusheva OA, Nagy N, Bery SK, Foster L, Avetisyan M, Johnson SL, Stenson WF, Goldstein AM, Heuckeroth RO.

Dev Biol. 2016 Jan 15;409(2):473-88. doi: 10.1016/j.ydbio.2015.09.023. Epub 2015 Nov 14.

4.

CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice.

Riehl TE, Santhanam S, Foster L, Ciorba M, Stenson WF.

Am J Physiol Gastrointest Liver Physiol. 2015 Dec 1;309(11):G874-87. doi: 10.1152/ajpgi.00123.2015. Epub 2015 Oct 1.

5.

Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.

Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ, Miyoshi H, Mack M, Schwendener RA, Hooton TM, Stappenbeck TS, Hansson GC, Stenson WF, Colonna M, Stapleton AE, Hultgren SJ.

EBioMedicine. 2014 Oct 24;1(1):46-57. doi: 10.1016/j.ebiom.2014.10.011. eCollection 2014 Nov.

6.

Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action.

Ciorba MA, Hallemeier CL, Stenson WF, Parikh PJ.

Curr Opin Support Palliat Care. 2015 Jun;9(2):157-62. doi: 10.1097/SPC.0000000000000134. Review.

7.

Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.

Shen Y, Ma J, Yan R, Ling H, Li X, Yang W, Gao J, Huang C, Bu Y, Cao Y, He Y, Wan L, Zu X, Liu J, Huang MC, Stenson WF, Liao DF, Cao D.

Clin Cancer Res. 2015 Mar 15;21(6):1466-76. doi: 10.1158/1078-0432.CCR-14-2072. Epub 2014 Dec 23.

8.

Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States.

Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, Kwon JH, Rheaume RL, Sandler RS.

Clin Gastroenterol Hepatol. 2015 Jun;13(6):1197-200. doi: 10.1016/j.cgh.2014.11.020. Epub 2014 Nov 21.

9.

The universe of arachidonic acid metabolites in inflammatory bowel disease: can we tell the good from the bad?

Stenson WF.

Curr Opin Gastroenterol. 2014 Jul;30(4):347-51. doi: 10.1097/MOG.0000000000000075. Review.

PMID:
24837228
10.

IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.

Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, Newberry RD, Stenson WF, Ciorba MA.

Gastroenterology. 2013 Aug;145(2):416-25.e1-4. doi: 10.1053/j.gastro.2013.05.002. Epub 2013 May 10.

11.

Preventing necrotising enterocolitis with amniotic fluid stem cells.

Stenson WF.

Gut. 2014 Feb;63(2):218-9. doi: 10.1136/gutjnl-2013-304653. Epub 2013 Apr 24. No abstract available.

PMID:
23616579
12.

The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.

Khurana SS, Riehl TE, Moore BD, Fassan M, Rugge M, Romero-Gallo J, Noto J, Peek RM Jr, Stenson WF, Mills JC.

J Biol Chem. 2013 May 31;288(22):16085-97. doi: 10.1074/jbc.M112.445551. Epub 2013 Apr 15.

13.

Postnatal growth in the intestine.

Stenson WF.

Curr Opin Gastroenterol. 2013 Mar;29(2):107-11. doi: 10.1097/MOG.0b013e32835d9ec3. Review. No abstract available.

PMID:
23286926
14.

CD36-dependent signaling mediates fatty acid-induced gut release of secretin and cholecystokinin.

Sundaresan S, Shahid R, Riehl TE, Chandra R, Nassir F, Stenson WF, Liddle RA, Abumrad NA.

FASEB J. 2013 Mar;27(3):1191-202. doi: 10.1096/fj.12-217703. Epub 2012 Dec 11.

15.

Hyaluronic acid regulates normal intestinal and colonic growth in mice.

Riehl TE, Ee X, Stenson WF.

Am J Physiol Gastrointest Liver Physiol. 2012 Aug 1;303(3):G377-88. doi: 10.1152/ajpgi.00034.2012. Epub 2012 May 3.

16.

Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2-mediated mechanism.

Riehl TE, Foster L, Stenson WF.

Am J Physiol Gastrointest Liver Physiol. 2012 Feb 1;302(3):G309-16. doi: 10.1152/ajpgi.00248.2011. Epub 2011 Oct 28.

17.

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner.

Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Nava GM, Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF.

Gut. 2012 Jun;61(6):829-38. doi: 10.1136/gutjnl-2011-300367. Epub 2011 Oct 24.

18.

Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity.

Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA.

Inflamm Bowel Dis. 2012 Jul;18(7):1214-20. doi: 10.1002/ibd.21849. Epub 2011 Aug 5.

19.

COX-1(+/-)COX-2(-/-) genotype in mice is associated with shortened time to carotid artery occlusion through increased PAI-1.

Riehl TE, He L, Zheng L, Greco S, Tollefsen DM, Stenson WF.

J Thromb Haemost. 2011 Feb;9(2):350-60. doi: 10.1111/j.1538-7836.2010.04156.x.

20.

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

Ciorba MA, Bettonville EE, McDonald KG, Metz R, Prendergast GC, Newberry RD, Stenson WF.

J Immunol. 2010 Apr 1;184(7):3907-16. doi: 10.4049/jimmunol.0900291. Epub 2010 Feb 24.

21.

Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells.

Walker MR, Brown SL, Riehl TE, Stenson WF, Stappenbeck TS.

J Biol Chem. 2010 Feb 12;285(7):5026-39. doi: 10.1074/jbc.M109.032672. Epub 2009 Dec 14.

22.

Hyaluronic acid and intestinal inflammation.

Stenson WF.

Curr Opin Gastroenterol. 2010 Mar;26(2):85-7. doi: 10.1097/MOG.0b013e328334b417. Review. No abstract available.

PMID:
19926985
23.

Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.

Zheng L, Riehl TE, Stenson WF.

Gastroenterology. 2009 Dec;137(6):2041-51. doi: 10.1053/j.gastro.2009.08.055. Epub 2009 Sep 2.

24.

Probiotic therapy in radiation-induced intestinal injury and repair.

Ciorba MA, Stenson WF.

Ann N Y Acad Sci. 2009 May;1165:190-4. doi: 10.1111/j.1749-6632.2009.04029.x. Review.

25.

Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines.

Katona BW, Anant S, Covey DF, Stenson WF.

J Biol Chem. 2009 Jan 30;284(5):3354-64. doi: 10.1074/jbc.M805804200. Epub 2008 Dec 3.

26.

What is the function of cyclooxygenases in the normal and inflamed intestine?

Stenson WF.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S104-5. doi: 10.1002/ibd.20700. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816737
27.
28.

Measurement of prostaglandins and other eicosanoids.

Stenson WF.

Curr Protoc Immunol. 2001 May;Chapter 7:Unit 7.33. doi: 10.1002/0471142735.im0733s33.

PMID:
18432845
29.

Toll-like receptors and intestinal epithelial repair.

Stenson WF.

Curr Opin Gastroenterol. 2008 Mar;24(2):103-7. doi: 10.1097/MOG.0b013e3282f44a2a. Review. No abstract available.

PMID:
18301257
30.

Challenges in IBD research: Assessing progress and rethinking the research agenda.

Stenson WF, Snapper SB.

Inflamm Bowel Dis. 2008 May;14(5):687-708. doi: 10.1002/ibd.20371. Review. No abstract available.

PMID:
18260124
31.

Enantiomeric deoxycholic acid: total synthesis, characterization, and preliminary toxicity toward colon cancer cell lines.

Katona BW, Rath NP, Anant S, Stenson WF, Covey DF.

J Org Chem. 2007 Nov 23;72(24):9298-307. Epub 2007 Oct 25.

PMID:
17958446
32.

Prostaglandins and epithelial response to injury.

Stenson WF.

Curr Opin Gastroenterol. 2007 Mar;23(2):107-10. Review.

PMID:
17268236
33.

Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury.

Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF, Stappenbeck TS.

J Clin Invest. 2007 Jan;117(1):258-69.

34.

Mechanisms of tissue protection and repair in inflammatory bowel disease.

Stenson WF.

Curr Opin Gastroenterol. 2001 Jul;17(4):313-7.

PMID:
17031176
35.

Cyclooxygenase expression in intestinal epithelial cells.

Houchen CW, Stenson WF.

Curr Opin Gastroenterol. 1999 Mar;15(2):97-9. No abstract available.

PMID:
17023926
36.

Rapid transient absorption and biliary secretion of enantiomeric cholesterol in hamsters.

Westover EJ, Lin X, Riehl TE, Ma L, Stenson WF, Covey DF, Ostlund RE Jr.

J Lipid Res. 2006 Nov;47(11):2374-81. Epub 2006 Aug 26.

37.

Reactive hemophagocytic syndrome complicating the treatment of inflammatory bowel disease.

James DG, Stone CD, Wang HL, Stenson WF.

Inflamm Bowel Dis. 2006 Jul;12(7):573-80.

PMID:
16804394
38.

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.

Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G; SUCCESS-I Investigators.

Am J Med. 2006 Mar;119(3):255-66. Erratum in: Am J Med. 2006 Sep;119(9):801.

PMID:
16490472
39.

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.

Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle GM, Robbins JL, Kent JD, Bloom BJ.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):203-11.

PMID:
16469681
40.

Fish oil fix.

Prescott SM, Stenson WF.

Nat Med. 2005 Jun;11(6):596-8. No abstract available.

PMID:
15937467
41.

Differential role of tumor necrosis factor receptors in TNBS colitis.

Ebach DR, Newberry R, Stenson WF.

Inflamm Bowel Dis. 2005 Jun;11(6):533-40.

PMID:
15905700
42.

The role of toll-like receptor 9 in the intestine.

Stenson WF.

Curr Opin Gastroenterol. 2005 May;21(3):360-2. Review. No abstract available. Erratum in: Curr Opin Gastroenterol. 2005 May;21(3):359.

PMID:
15818159
43.
44.

Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis.

Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R.

Arch Intern Med. 2005 Feb 28;165(4):393-9.

PMID:
15738367
45.

Prostaglandins and the epithelial response to radiation injury in the intestine.

Stenson WF.

Curr Opin Gastroenterol. 2004 Mar;20(2):61-4. No abstract available.

PMID:
15703622
46.
47.

Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression.

Anant S, Murmu N, Houchen CW, Mukhopadhyay D, Riehl TE, Young SG, Morrison AR, Stenson WF, Davidson NO.

Gastroenterology. 2004 Oct;127(4):1139-49.

PMID:
15480992
48.

Dynamic antagonism between RNA-binding protein CUGBP2 and cyclooxygenase-2-mediated prostaglandin E2 in radiation damage.

Murmu N, Jung J, Mukhopadhyay D, Houchen CW, Riehl TE, Stenson WF, Morrison AR, Arumugam T, Dieckgraefe BK, Anant S.

Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13873-8. Epub 2004 Sep 9.

49.

Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib.

Goldstein JL, Eisen GM, Agrawal N, Stenson WF, Kent JD, Verburg KM.

Aliment Pharmacol Ther. 2004 Sep 1;20(5):527-38.

50.

Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.

Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF.

Gastroenterology. 2003 Dec;125(6):1762-73.

PMID:
14724829

Supplemental Content

Loading ...
Support Center